James Green
Translating the complexity of a world in motion into the intelligence you need.
About This Column
James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.
Displaying items 201-220 of 525 in total
StageOne Ventures Closes $165M Fund to Back Israel's AI Infrastructure
AI vs. AI: Healthcare's New War on Deepfake Medical Fraud
Sun Life CFO Charts Course Amid Market Volatility at RBC Conference
Whirlpool Ups Climate Goals with New Science-Backed 2050 Target
'History in 60' Unearths Canada's Overlooked Disability Narratives
Robotic Phlebotomist Gets $70M to Tackle Healthcare Staffing Crisis
Root Evidence Links Cyber Risk to Financial Loss with New Scanner
Dechert Taps Microsoft Cyber Expert in AI Legal Talent Arms Race
Palvella Unites Nonprofits to Shine Light on Rare Microcystic LMs
Ultralife Takes Q4 Loss on Rebrand, Hiding Strong Operational Growth
Canadian Firm Unveils Cement That Halves Portland, Boosts Green Building
Guidelight Taps Kelly Jones to Spearhead National Mental Health Push
New Hope for Tourette's as Novel Drug Enters Expanded Access Program
Swiss Precision for Nordic Wealth: Prospera Group's Digital Expansion
United Educators Taps Veteran for New Strategic Engagement Role
Postscript and Tie Tackle Cookie-Less Commerce with New SMS Tech
GoodRx and Lilly Offer Employers a New Path to Zepbound Access
FuelPositive’s Green Vision Clouded by Regulatory Non-Compliance
Orlando Industrial Sale Proves Value-Add Strategy in Hot Market
